Hyperthermic intraperitoneal chemotherapy is an independent risk factor for development of acute kidney injury

Dagel T., Misirlioglu S., Tanju S., AFŞAR B. , Selcukbiriciks F., Erus S., ...Daha Fazla

JOURNAL OF BUON, cilt.23, sa.5, ss.1528-1533, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Konu: 5
  • Basım Tarihi: 2018
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.1528-1533


Purpose: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) or hyperthermic intrapleural chemotherapy (HIC) has been established as the new treatment modality for selected patients with peritoneal and pleural malignancies. The purpose of the study was to compare the development of acute kidney injury (AKI) in patients who received intravenous cisplatin alone, HIPEC and underwent surgery.